In the absence of specific drugs designed for COVID-19, researchers and clinicians are trying find already licensed products to treat severe cases of the illness. This concept is called drug repurposing.

Continue reading

Try our 7-day free trial and access the full article with citations and resources.

Try For Free Already have an account? Sign in